Deprescribing im Alter

Zusammenfassung

Ältere Patienten wenden zumeist mehrere Arzneimittel zur Behandlung ihrer Erkrankungen an. Auch wenn diese Medikamente zur Therapie von Beschwerden und Symptomen verordnet werden, so können ihre Nebenwirkungen, speziell für ältere Patienten mit vielen Arzneimitteln, schädlich sein. Solche unangemessenen Medikamente sind für 11% der Krankenhauseinweisungen verantwortlich. Obwohl dieser Umstand bekannt ist, sind Daten, wie man diese Medikation für diese verletzliche Population beendet, nur spärlich vorhanden. Forschungsdaten belegen, dass eine präzise Struktur und sorgfältige Planung für einen erfolgreichen Deprescribing-Prozess unabdingbar sind, was auch bedeutet, verschiedene Beteiligte in diesen Prozess miteinzubeziehen, um für Patienten ein optimales Ergebnis zu erzielen. Bislang existiert keine Vorgabe, wie Phytopharmaka in diesen Prozess eingebunden werden können. Dieser Artikel liefert eine Definition für Deprescribing im deutschsprachigen Raum, eine Beschreibung der strukturierten Vorgehensweise und bietet einen Ansatz zur Einbeziehung von Phytotherapeutika in den Deprescribing-Prozess.

ABSTRACT

Older people are often taking several medications for a number of medical conditions. Although physicians prescribe medications to treat diseases and symptoms, there may be also harmful side effects, especially in older people taking several medications. This inappropriate polymedication is held accountable for 11% of all hospital admissions. But data on how to stop medication in this vulnerable population are scarce. Present research shows the necessity of a clear structure and careful planning for a successful deprescribing process. This includes the involvement of multidisciplinary team-members to ensure optimal benefit for a patient. The role of herbal medicinal drugs in the context of the deprescribing process is not yet defined. This article provides a definition for deprescribing, a structured process description and supplies an approach how to include herbal medicinal drugs in the deprescribing process.

Schlüsselwörter

Deprescribing - Definition - Polymedikation - strukturierter Prozess - interdisziplinär

Key words

Deprescribing - definition - polypharmacy - structured process - interdisciplinary

Publication History

Article published online:
08 September 2022

• Literatur

• 1 Salahudeen MS. Deprescribing medications in older people: a narrative review. Drugs Today 2018; 54: 489-498
• 2 van der Velde N, Minhas JS. Appropriate deprescribing in older people: a challenging necessity. Commentary to accompany themed collection on deprescribing. Age Ageing 2021; 50: 1516-1519
• 3 World Health Organization. Medication Safety in Polypharmacy. 2019. Im Internet: https://apps.who.int/iris/rest/bitstreams/1235792/retrieve; Zugriff: 22.06.2022
• 4 Delgado J, Jones L, Bradley MC. et al. Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes. Age Ageing 2021; 50: 457-464
• 5 Lundby C, Jensen J, Larsen SP. et al. Use of medication among nursing home residents: a Danish drug utilisation study. Age Ageing 2020; 49: 814-820
• 6 Scott IA, Hilmer SN, Reeve E. et al. Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Intern Med 2015; 175: 827-834
• 7 Farrell B, Richardson L, Raman-Wilms L. et al. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm 2018; 14: 18-25
• 8 Reeve E, Gnjidic D, Long J. et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80: 1254-1268
• 9 Woodward MC. Deprescribing: achieve better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323-328
• 10 Scottish Government Polypharmacy Model of Care Group, ed. Polypharmacy guidance: realistic prescribing. 3^rd ed. Edinburgh; 2018. Im Internet: https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-2018.pdf; Zugriff 23.07.2021
• 11 Mishori R. What needs to change to make deprescribing doable. Fam Pract Manag 2018; 25: 5-6
• 12 Frank C, Weir E. Deprescribing for older patients. CMAJ 2014; 186: 1369-1376
• 13 Potter K, Flicker L, Page A. et al. Deprescribing in frail older people: A randomised controlled trial. PLoS ONE 2016; 11: e0149984
• 14 Roux B, Sirois C, Simard M. et al. Potentially inappropriate medications in older adults: a population-based cohort study. Fam Pract 2020; 37: 173-179
• 15 Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr 2018; 18: 239
• 16 Pazan F, Weiß C, Wehling M. Die FORTA-Liste – „Fit for the aged“. Im Internet: https://www.umm.uni-heidelberg.de/index.php?eID=tx_nawsecuredl&u=0&g=0&t=1590763051&hash=71d8ee893d4b7258b04e9b5440ad5aacf1736e3c&file=fileadmin/medma/Lehrstuehle/Wehling/FORTA-Liste_2018_nur_Bewertungen.pdf; Zugriff: 23.07.2021
• 17 Holt S, Schmiedl S, Thürmann PA. PRISCUS-Liste potentiell inadäquater Medikation für ältere Menschen. Im Internet: http://priscus.net/download/PRISCUS-Liste_PRISCUS-TP3_2011.pdf Zugriff: 23.07.2021
• 18 Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 2015; 71: 861-875
• 19 Seppala LJ, Petrovic M, Ryg J. et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing 2021; 50: 1189-1199
• 20 Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 2021; 50: 465-471
• 21 Leitliniengruppe Hessen. Hausärztliche Pharmakotherapie: Hausärztliche Leitlinie Multimedikation. Empfehlungen zum Umgang mit Multimedikation bei Erwachsenen und geriatrischen Patienten. 2013. Im Internet: www.pmvforschungsgruppe.de/pdf/03_publikationen/multimedikation_ll.pdf Zugriff: 27.06.2022
• 22 O’Mahony D, O’Sullivan D, Byrne S. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2014; 44: 213-218
• 23 Farris KB, Carter BL, Xu Y. et al. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res 2014; 14: 406
• 24 van der Meer HG, Wouters H, Pont LG. et al. Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: A randomised controlled trial. BMJ Open 2018; 8: e019042
• 25 Page AT, Potter K, Clifford R. et al. Deprescribing in older people. Maturitas 2016; 91: 115-134
• 26 Alshamrani M, Almalki A, Qureshi M. et al. Polypharmacy and medication-related problems in hemodialysis patients: A call for deprescribing. Pharmacy (Basel) 2018; 6: 76
• 27 McNicholl IR, Gandhi M, Hare CB. et al. A pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients. Pharmacotherapy 2017; 37: 1498-1506
• 28 Whitman A, DeGregory K, Morris A. et al. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: A pilot study. Support Care Cancer 2018; 26: 4105-4113
• 29 Baumgartner AD, Clark CM, LaValley SA. et al. Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation?. J Clin Pharm Ther 2020; 45: 453-461
• 30 Khazaka M, Laverdière J, Li CC. et al. Medication appropriateness on an acute geriatric care unit: the impact of the removal of a clinical pharmacist. Age Ageing 2021; 50: 527-533
• 31 Arzneimittelkommission der Deutschen Apotheker (AMK), Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ), Bundesarbeitsgemeinschaft Selbsthilfe (BAG Selbsthilfe) et al. NVL Chronische Herzinsuffizienz – Langfassung, 3. Aufl. 2019. Im Internet: https://www.leitlinien.de/themen/herzinsuffizienz/3-auflage Zugriff: 27.06.2022
• 32 Fornara P, Madersbacher S, Vahlensieck W. et al. Phytotherapy adds to the therapeutic armamentarium for the treatment of mild-to-moderate lower urinary tract symptoms in men. Urol Int 2020; 104: 333-342
• 33 Prely H, Herledan C, Caffin AG. et al. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases. J Cancer Res Clin Oncol 2022; 148: 707-718
• 34 Saller R, Kasper S, Dimpfel W. et al. Phytotherapie in der Geriatrie und Gerontologie. Forsch Komplementmed 2014; 21: 2-18
• 35 Savaskan E, Mueller H, Hoerr R. et al. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. Int Psychogeriatr 2018; 30: 285-293
• 36 Phelps K, Hassed C. Geriatric Medicine: General Practice: The Integrative Approach Series. Sydney: Churchill Livingstone/Elsevier; 2012
• 37 deAzevedo Pribitkin E. Herbal medicine and surgery. Semin Integr Med 2005; 3: 17-23